Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 18/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | FKBP4 | Q02790 | 1/20 | 1.00 |
| ▸ | FKBP5 | Q13451 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gpi-1046 SCHEMBL4766380 | 1.00 | FKBP1A (1.00) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL2191097 | 0.99 | FKBP1A (0.98) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL7324245 | 0.99 | FKBP1A (0.98) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL2542494 | 0.98 | FKBP1A (0.96) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL182073 | 0.97 | FKBP1A (0.95) | FKBP1AMTORFKBP4FKBP5 | |
| SCHEMBL5965941 | 0.97 | FKBP1A (1.00) | FKBP1AMTORFKBP4FKBP5 | |
| SCHEMBL7246114 | 0.94 | FKBP1A (0.90) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL2537059 | 0.94 | FKBP1A (0.89) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL19386253 | 0.93 | FKBP1A (0.87) | FKBP1AMTORFKBP4FKBP5 | |
| SCHEMBL7767569 | 0.92 | FKBP1A (1.00) | FKBP1AMTORFKBP4FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 50543 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745155-A1 | POWDER CONTAINING PARTICLES OF GELATIN DERIVATIVE AND APPLICATION OF SAME IN MEDICAL TREATMENT | National Institute for Materials Science (JP) | 2026-05-20 | — | — | EP | claimed |
| EP-4741421-A1 | FAB-ARM EXCHANGE-PREVENTING FC VARIANTS FROM WHICH EFFECTOR FUNCTIONS ARE REMOVED | Korea University Research and Business Foundation (KR) | 2026-05-13 | — | — | EP | claimed |
| US-12622973-B2 | Rejuvenation of CAR T cell | PURDUE RESEARCH FOUNDATION (US) | 2026-05-12 | — | — | US | claimed |
| EP-4118431-B1 | INHIBITION OF FKBP1A FOR THE TREATMENT OF TRIPLE-NEGATIVE MAMMARY CARCINOMA | HEINRICH HEINE UNIV DUESSELDORF (DE) | 2026-05-06 | — | — | EP | claimed |
| US-20260117199-A1 | ARTIFICIAL COMPLEX FOR TETHERING CHROMATIDS OR CHROMOSOMES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12599701-B2 | Drug delivery system and methods of using the same | AXOGEN CORPORATION (US) | 2026-04-14 | — | — | US | claimed |
| EP-4282978-B1 | A UNIVERSAL PLATFORM FOR CAR THERAPY TARGETING A NOVEL ANTIGENIC SIGNATURE OF CANCER | GAVISH GALILEE BIO APPL LTD (IL) | 2026-04-01 | — | — | EP | claimed |
| EP-4713473-A1 | SYSTEM AND METHOD FOR CHECKING THE ABILITY OF A PROTEIN OF INTEREST TO ACT AS A SUBSTRATE FOR AN ENZYME | Julius-Maximilians-Universität Würzburg, in Vertretung des Freistaates Bayern (DE) | 2026-03-25 | — | — | EP | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| WO-1993003364-A1 | DETECTION OF IMMUNOSUPPRESSANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1993-02-18 | — | — | WO | claimed |
| US-5164495-A | ESTERIFICATION, TRIETHYLAMINE | ABBOTT LABORATORIES (US) | 1992-11-17 | — | — | US | claimed |
| WO-1992019745-A1 | RFKBP: A NOVEL PROLYL ISOMERASE AND RAPAMYCIN/FK506 BINDING PROTEIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1992-11-12 | — | — | WO | claimed |
| WO-1992008474-A2 | TREATMENT OF LUNG DISEASES | THE NATIONAL HEART & LUNG INSTITUTE (GB) | 1992-05-29 | — | — | WO | claimed |
| WO-1992004055-A1 | IMMUNOSUPPRESSANT COMPOSITION | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1992-03-19 | — | — | WO | claimed |
| WO-1992000739-A1 | 3-PHENYL-5,6-DIHYDROBENZ[C]ACRIDINE-7-CARBOXYLIC ACIDS AND RELATED COMPOUNDS AS IMMUNOSUPPRESIVE AGENTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-01-23 | — | — | WO | claimed |
| WO-1991019498-A1 | TREATMENT OF ORGAN TRANSPLANTATION REJECTION | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1991-12-26 | — | — | WO | claimed |
| CN-1056240-A | INHIBITION NF ALLOGRAFT AND CONCORDANT XENOGRAFT REJECTION | IMUTRAN LTD (GB) | 1991-11-20 | — | — | CN | claimed |
| WO-1991004321-A1 | RECEPTOR FOR FK-506 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1991-04-04 | — | — | WO | claimed |
| EP-0401747-A2 | Use of rapamycin and derivatives and prodrugs thereof in the manufacture of a medicament for inhibiting transplant rejection in mammals | Calne, Roy (GB) | 1990-12-12 | — | — | EP | claimed |